What is onconova therapeutics? Onconova Therapeutics was incorporated in 1998 in Delaware and began trading on the NASDAQ stock exchange under the ticker symbol ONTX in July, 2013. Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.What is the onconova pint pharma alliance? The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials. March 5, 2018 – Onconova entered into a License Agreement with Pint Pharma GmbH to commercialize rigosertib in Latin America.Who is onconovas cmo? In his role as Onconova’s CMO, Dr. Gelder leads ON 123300’s clinical development, facilitates the progression of rigosertib’s investigator-initiated trials, and evaluates potential product candidates for in-licensing.What is ononconova therapeutics stock symbol? Onconova Therapeutics was incorporated in 1998 in Delaware and began trading on the NASDAQ stock exchange under the ticker symbol ONTX in July, 2013. Click here to view our Corporate Presentation.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase
Onconova Therapeutics, Newton, Pennsylvania. 1,103 likes · 1 was here. Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing